CONCENTRIS RESEARCH MANAGEMENT GMBH

Their core work

Concentris is a specialized research project management company that provides professional consortium management, administration, and coordination support to large-scale EU health research projects. Rather than conducting scientific research themselves, they handle the operational backbone of multi-partner consortia — project governance, reporting, financial management, ethics compliance, and communication. Their portfolio of 19 H2020 projects spanning psychiatry, liver disease, childhood health, and digital health shows they are a trusted management partner for complex biomedical research consortia across Europe.

What they specialise in

How they've shifted over time

In their earlier H2020 period (2016–2018), Concentris managed a diverse spread of projects including developmental health (LIFECYCLE, RECAP preterm), nutrition and behavior (Eat2beNICE), psychiatric stratification (PRISM), and even an outlier in space technology (DISCOVERER). From 2019 onward, their portfolio concentrated sharply on liver disease (MICROB-PREDICT, DECISION, A-TANGO), metabolic disorders (PRIME, GO-DS21), and digital health infrastructure (FeatureCloud, TIMESPAN). This shift suggests they built deep domain credibility in hepatology and metabolic disease management, while also gaining competence in data-intensive, multi-omics consortium operations.

Concentris is increasingly embedded in liver disease and digital health consortia, making them a strong management partner for future projects combining clinical hepatology with computational approaches.

How they like to work

Concentris operates exclusively as a consortium participant — they have never coordinated any of their 19 H2020 projects. This is consistent with their role as a professional project management service provider rather than a research-performing organization. With 211 unique partners across 26 countries, they function as a broadly connected hub in European health research, continuously joining new consortia rather than repeatedly working with the same partners. For potential collaborators, this means Concentris brings operational reliability and a vast network of contacts accumulated across dozens of major consortia.

With 211 unique consortium partners across 26 countries, Concentris has one of the broadest collaboration networks for an SME of its size, connecting them to universities, hospitals, and research institutes across virtually all EU member states. Their Munich-area base positions them centrally in the German biomedical research ecosystem.

What sets them apart

Concentris occupies a distinctive niche as a dedicated research management SME — not a university, not a hospital, not a tech company, but a professional service firm that makes complex health consortia run smoothly. Their consistent participation across 19 projects without ever being coordinator shows they are valued specifically for operational management expertise rather than scientific content. For consortium builders, adding Concentris means offloading administrative burden onto a team with proven experience managing EU project finances, reporting, ethics, and multi-partner communication.

Highlights from their portfolio

• MICROB-PREDICT
  Largest single project budget (EUR 685,000) and represents their deepening focus on liver disease with multi-omics and microbiome approaches.
• DISCOVERER
  A complete outlier — a space technology project on very low Earth orbit platforms, demonstrating their ability to manage consortia well outside their health core.
• FeatureCloud
  Bridges health and cybersecurity through federated machine learning and blockchain for health records, signaling Concentris's growing capacity in digital health data governance.